NCT03276312View on ClinicalTrials.gov

Autologous Micro-fragmented Adipose Tissue in the Treatment of Minor Amputations of Diabetic Foot

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Diabetic Foot
Interventions
DEVICE

Lipogems

Lipogems® is an innovative system that, starting from minimum quantities of autologous lipoaspirate, provides, with a minimal manipulation, a micro-fragmented and non-expanded adipose tissue product

Trial Locations (1)

41100

University of Modena and Reggio Emilia, Modena

All Listed Sponsors
lead

University of Modena and Reggio Emilia

OTHER

NCT03276312 - Autologous Micro-fragmented Adipose Tissue in the Treatment of Minor Amputations of Diabetic Foot | Biotech Hunter | Biotech Hunter